Increasing
recognition
calcium
pathogenesis
cardiovascular disease
stimulated
research
calcium channel blocking agents
treatment
cardiovascular diseases
favorable
efficacy
tolerability
agents
therapeutic modalities
Clinical applications
calcium channel blockers
tissue selectivity
verapamil
diltiazem
equipotent
actions
heart
vascular smooth muscle
dihydropyridine calcium channel blockers
group
peripheral vasodilator agents
minimal
electrophysiologic effects
cardiac nodal
conduction tissue
dihydropyridine
United States
nifedipine controls angina
hypertension
depression
cardiac function
group
calcium channel blockers
indications
therapy
daily
dosage
nitrendipine
nisoldipine
administration schedule
patient
compliance
long-term
therapy
hypertension
coronary vasodilating properties
nisoldipine
investigation
agent
angina
Selectivity
cerebrovascular
nimodipine
treatment
subarachnoid hemorrhage
migraine headache
dementia
stroke
dihydropyridine calcium channel blockers
tolerated
headache
facial flushing
palpitations
edema
nausea
anorexia
dizziness
adverse effects
